Lesch-Nyhan Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease (NCT01751802) | Emalex Biosciences Inc. | 2012-12-01 |
| Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease (NCT01065558) | Psyadon Pharma | 2010-02-01 |
Track Lesch-Nyhan Disease automatically
Every clearance here is in the API, with alerts when new ones post.